Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Publication Date Organization
Jul
5
2024
 Urinary Catheter Fraud Sparks Proposed Medicare Payment Changes for ACOS K&L Gates LLP
Jul
5
2024
 WHALE HUNTING: Temu Facing Another TCPA Class Action After Its Arbitration Clause Deemed Unenforceable Troutman Amin, LLP
Jul
5
2024
 Ozempic Lawsuit Overview Oberheiden P.C.
Jul
3
2024
 NNI and NNCO Will Hold July 24 Workshop on “Responsible Development, Social Science, and the National Nanotechnology Initiative” Bergeson & Campbell, P.C.
Jul
3
2024
 This Week in 340B: June 28 – July 1, 2024 McDermott Will & Emery
Jul
3
2024
 Loper Bright Could Shift Outlook for FDA Legal Challenges McDermott Will & Emery
Jul
3
2024
 FDA Authorizes First Menthol-Flavored Vapor Products Keller and Heckman LLP
Jul
3
2024
 Chobani Petitions FDA to Amend Yogurt Standard of Identity Keller and Heckman LLP
Jul
3
2024
 EPA Announces Final Cancellation Order and Updates to Existing Stocks Provisions for Several Chlorpyrifos Products Bergeson & Campbell, P.C.
Jul
2
2024
 Federal Circuit Clarifies Rules for Skinny Labelling for Generics and Biosimilar Companies Polsinelli PC
Jul
2
2024
 Healthcare Execs Face Federal Drug Charges in Landmark Telehealth Case Bradley Arant Boult Cummings LLP
Jul
2
2024
 FDA to Revoke Authorization for Brominated Vegetable Oil in Food Keller and Heckman LLP
Jul
2
2024
 Unpacking Averages: Intended Use Words Most Common to Devices That Require Clinical Trials Epstein Becker & Green, P.C.
Jul
1
2024
 Ten Things CPG Companies Should Do to Manage Co-Manufacturer Relationships K&L Gates LLP
Jul
1
2024
 We Get Work: Life Sciences and Real-World Accommodation Scenarios [Podcast] Jackson Lewis P.C.
Jul
1
2024
 It Ain’t Over ‘til It’s Over: IRS Reminds Taxpayers That Section 280E Applies to Marijuana Companies Until Rescheduling Becomes Law Bradley Arant Boult Cummings LLP
Jun
29
2024
 Cheers to this! Good News for the North Carolina Alcoholic Beverage Industry Ward and Smith, P.A.
Jun
28
2024
 Biden-Harris Administration Announces Actions to Accelerate U.S. Domestic Biomanufacturing Capacity Bergeson & Campbell, P.C.
Jun
28
2024
 Minnesota Department of Health Highlights Recent Publications on PFAS Bioaccumulation and PFAS in Infant Formula Bergeson & Campbell, P.C.
Jun
28
2024
 Old North State Report – June 28, 2024 Nelson Mullins
Jun
28
2024
 In Purdue Pharma, the Supreme Court Fires a Canon of Construction Through Non-Consensual Third-Party Releases (US) Squire Patton Boggs (US) LLP
Jun
28
2024
 FDA Releases Update of Priority Guidance Topics for Foods Program Keller and Heckman LLP
Jun
28
2024
 Codifying the Experimental Use Exception? USPTO Seeks Public Input Womble Bond Dickinson (US) LLP
Jun
28
2024
 SCOTUS Update: Supreme Court Clarifies Organizational Standing in FDA-Related Ruling ArentFox Schiff LLP
Jun
27
2024
 In Purdue Pharma, Supreme Court Rules That Nonconsensual Releases Are A Nonstarter Miller Canfield
Jun
27
2024
 Aye, What’s the Deal with THCA? Unraveling Hemp’s Legal Knots Norris McLaughlin P.A.
Jun
27
2024
 E for Effort? PI Analysis in Trade Secret Suit Riddled with Errors McDermott Will & Emery
Jun
26
2024
 July 1 Deadline Looms for Cannabis Operators to Maintain and Renew Their Licenses by Entering into Labor Peace Agreements Sheppard, Mullin, Richter & Hampton LLP
Displaying 477 - 504 of 11742
Subscribe to The 10 Latest Biological, Life Sciences, and Cleantech Law Articles
 
NLR Logo
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins